Review of: Singer, Andre and Street, Brian V. (eds.): Zande Themes. Essays to Sir Edward Evans-Pritchard by Hardman, C

Review of: Mayer, Philip (ed.): Socialization: The Approach from Social Anthropology (A.S.A. Monograph 8) by Hardman, C

Children in the playground by Hardman, C

Can there be an anthropology of children? by Hardman, C

Interleukin-33, friend and foe in type-2 immune responses by Hardman, C, Ogg, G

Portion size normality and additional within-meal food intake: two crossover laboratory experiments by Haynes, A, Hardman, C, Halford, J, Jebb, S, Robinson, E

Visual perceptions of portion size normality and intended food consumption: A norm range model by Haynes, A, Hardman, C, Makin, A, Halford, J, Jebb, S, Robinson, E

Group 2 innate lymphoid cells express functional NKp30 receptor inducing type 2 cytokine production by Ogg, G, Salimi, S, Xue, L, Jolin, H, Hardman, C, Cousins, D, McKenzie, A

Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s) by Sandham, D, Chen, W, Hardman, C, Luo, J, Xue, L, Ogg, G, Erpenbeck, V

Fevipiprant, a selective prostaglandin D-2 receptor 2 antagonist, potently inhibits chemotaxis and cytokine production by group 2 innate lymphoid cells by Xue, L, Hardman, C, Chen, W, Batty, P, Ogg, G, Erpenbeck, V, Sandham, D

Phospholipase activity of Acyloxyacyl Hydrolase induces IL‐22‐producing CD1a‐autoreactive T cells in individuals with psoriasis by Singh, R, Chen, Y, Ng, JSW, Cain, D, Etherington, R, Hardman, C, Ogg, G

Group 2 innate lymphoid cells express functional NKp30 receptor inducing type 2 cytokine production by Salimi, M, Xue, L, Jolin, H, Hardman, C, Cousins, D, McKenzie, A, Ogg, G

Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s) by Chen, W, Hardman, C, Batty, P, Luo, J, Wu, Y, Xue, L, Ogg, G, Sandham, D, Erpenbeck, V

Psoriatic T cells recognize neolipid antigens generated by mast cell phospholipase delivered by exosomes and presented by CD1a by Cheung, K, Jarrett, R, Subramaniam, S, Salimi, M, Gutowska-Owsiak, D, Chen, Y, Hardman, C, Xue, L, Cerundolo, V, Ogg, G

Effects of steroids in cultured human type-2 cytokine producing cells by Luo, J, Go, S, Stoger, L, Hardman, C, Salimi, M, Shrimanker, R, Hynes, G, Wang, O, Ogg, G, Pavord, I, Xue, L

Role of NS1 antibodies in the pathogenesis of acute secondary dengue infection by Jayathilaka, D, Gomes, L, Jeewandara, C, Jayarathna, G, Herath, D, Perera, P, Fernando, S, Wijewickrama, A, Hardman, C, Ogg, G, Malavige, G

Proof-of-concept clinical trial of etokimab shows a key role for IL-33 in atopic dermatitis pathogenesis by Chen, Y, Gutowska-Owsiak, D, Hardman, C, Westmoreland, M, Mackenzie, T, Cifuentes, L, Waithe, D, Lloyd-Lavery, A, Marquette, A, Londei, M, Ogg, G

Fevipiprant, a selective prostaglandin D2 receptor 2 antagonist, inhibits human group 2 innate lymphoid cell aggregation and function by Hardman, C, Chen, W, Luo, J, Batty, P, Chen, Y, Nahler, J, Wu, Y, Pavord, I, Erpenbeck, V, Sandham, D, Xue, L, Ogg, G

CD1a presentation of endogenous antigens by group 2 innate lymphoid cells by Hardman, C, Chen, Y, Salimi, M, Jarrett, R, Johnson, D, Jarvinen, V, Owens, R, Repapi, E, Cousins, D, Barlow, J, McKenzie, A, Ogg, G

Resistance to apoptosis underpins the corticosteroid insensitivity of group 2 innate lymphoid cells by Luo, J, Wu, Y, Shrimanker, R, Go, S, Ye, Y, Hardman, C, Nahler, J, Chen, Y, Stöger, L, Zeng, N, Liu, W, Reed, L, Tolkovsky, A, Klenerman, P, Ogg, G, Pavord, I, Xue, L